References
Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. Journal of Clinical Oncology 7: 1646–1654, 1989
Hrushesky WJ. Circadian timing of cancer chemotherapy. Science 228: 73–79, 1985
Hrushesky WJ, vonRoemeling R, Lanning RM. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. Journal of Clinical Oncology 8: 1504–1513, 1990
Kemeny MM, Battifora H, Blaney DW, Cecchi G, Goldberg DA, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Annals of Surgery 202: 176–181, 1985
Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57: 492–498, 1986
Kemeny N, Daly J, Oderman P, Shike M, Chun H, et al. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. Journal of Clinical Oncology 6: 595–600, 1984
Kemeny N, Daly J, Reichman B, Geller N, Botet J, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Annals of Internal Medicine 107: 459–465, 1987
Rougier P, Hay JM, Escat J, Laplanche A, Eilas D, et al. A controlled multicentric trial of intrahepatic chemotherapy (IHC) vs standard palliative treatment for colorectal liver metastases. American Society of Clinical Oncology, Poster 403, May 1990
Seiter K, Kemeny N, Berger M, Niedzwiecki, Chapman D, et al. A randomised trial of intrahepatic (IH) infusion of FUDR with dexamethasone (d) vs FUDR alone in the treatment of metastatic colorectal cancer. American Society of Clinical Oncology Proceedings 9: 418, 1990
Stagg R, Venook A, Chase J, Grobman B, Lewis B, et al. Alternating hepatic IA FUDR & IA 5FU for colorectal liver metastases. International Conference on Advances in Regional Cancer Therapy, Berchtesgaden, West Germany, June 5–7, 1989. Abstract IV, 1989
von Roemeling R, Hrushesky WJ. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. Journal of Clinical Oncology 7: 1710–1719, 1989
Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. Journal of Clinical Oncology 8: 1885–1893, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kemeny, M.M. Continuous Hepatic Artery Infusion (CHAI) as Treatment of Liver Metastases. Drug-Safety 6, 159–165 (1991). https://doi.org/10.2165/00002018-199106030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199106030-00001